That GLP-1 moreover is a satiety signal that facilitates weight loss and— as shown later—ameliorates the cardiac function in diabetes has made GLP-1 an obvious drug target for treatment of type 2 diabetes mellitus. Here, GCG is linked to type 2 diabetes mellitus.